MedTrace Logo

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

NCT07343245 · Status: RECRUITING · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-01-15

No results posted yet for this study

Summary

Drug-Drug Interaction between DW4421 and three different kinds of NSAIDs

Conditions

  • Healthy Adult

Interventions

DRUG

DW4421

QD

DRUG

DW4421-N1

BID

DRUG

DW4421-N2

BID

DRUG

DW4421-N3

QD

Sponsors & Collaborators

  • Daewon Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2026-02-22
Completion
2026-06-17

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07343245 on ClinicalTrials.gov